Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New discoveries about nitric oxide can provide drugs for schizophrenia

21.11.2007
Problems with memory and social function in patients with schizophrenia may result from an imbalance in the brain's nitric oxide system. A dissertation from the Sahlgrenska Academy shows that rats with characteristics of schizophrenia regain normal brain function if they receive drugs that reduce the production of nitric oxide in the brain.

Schizophrenia is a serious and common disease that can cause hallucinations, delusions and apathy. Problems with memory, social cognition and other intellectual abilities are also common.

"Schizophrenic patients can be treated with anti-psychotic drugs, but the treatment does not help cognitive disturbances or impaired social function to any appreciable degree. We believe that this is due to an imbalance in the brain's nitric oxide system, and if this is the case, we may be able to develop a completely new type of treatment," says pharmacologist Caroline Wass.

In these studies, rate and mice were given a drug called phencyclidine. This substance causes a schizophrenia-like state in humans.

... more about:
»Oxide »Wass »function »nitric »schizophrenia

"Rats and mice don't become schizophrenic, but the drug has a similar effect on thought processes in rodents to the effect it has in humans," says Caroline Wass.

The animals' learning capacity, memory and social interaction were measured using several different behaviour models. When the animals were treated with a substance that blocks brain nitric oxide production, they became resistant to the schizophrenia-like effects of phencyclidine.

The research team will shortly initiate a patient study in order to find out whether blocking brain nitric oxide production can alleviate cognitive disturbances in patients with schizophrenia.

"In the future it is possible that drugs that affect the regulation of nitric oxide in the brain can be used to supplement currently existing anti-psychotic agents. The hope is that nitric oxide inhibiting drugs will alleviate the cognitive disturbances that also lie behind the impairments of social function, significantly improving the chances of a good life for schizophrenic patients," says Caroline Wass.

SCHIZOPHRENIA FACTS
Schizophrenia is a psychiatric illness that affects 1% of the population. There is no cure, but the psychotic symptoms can be treated with psychotropic drugs. The illness often first appears in the twenties. It is usually chronic, and most sufferers never return to work or to full-time education.
Dissertation for research doctorate in medicine from the Sahlgrenska Academy, Institute of Neuroscience and Physiology
Title of dissertation: Cognition and social behaviour in schizophrenia:
An animal model investigating the potential role of nitric oxide
The dissertation will be publically defended on Wednesday 14th December at 09.00, Room 2118, Arvid Wallgrens Backe, hus 2, Göteborg.

For further information contact: Caroline Wass, Pharmacologist, telephone: +46 (0)31 786 3420, +46 (0)70 498 4958, email: caroline.wass@pharm.gu.se Supervisors: Associate professor Lennart Svensson, telephone: +46 (0)31 786 3402, email: lennart.svensson@pharm.gu.se Professor Jörgen Engel, telephone: +46 (0)31 786 3416, email: jorgen.engel@pharm.gu.se Professor Trevor Archer, telephone: +46 (0)31 786 4694, email: trevor.archer@psy.gu.se Dr. Daniel Klamer PhD, telephone: +46 (0)31 786 3403, email: daniel.klamer@pharm.gu.se

Pressofficer: Elin Lindström Claessen; elin.lindstrom@sahlgrenska.gu.se;
+46-70 829 43 03

Elin Lindström Claessen | idw
Further information:
http://www.vr.se

Further reports about: Oxide Wass function nitric schizophrenia

More articles from Life Sciences:

nachricht Transforming plant cells from generalists to specialists
07.12.2016 | Duke University

nachricht What happens in the cell nucleus after fertilization
06.12.2016 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Predicting unpredictability: Information theory offers new way to read ice cores

07.12.2016 | Earth Sciences

Sea ice hit record lows in November

07.12.2016 | Earth Sciences

New material could lead to erasable and rewriteable optical chips

07.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>